Vous êtes ici

MindBio Therapeutics Corp.

Liste d'échange: 
CSE
Statut: 
Active
Industrie: 
Life Sciences
Symbole: 
MBIO
Indice CSE: 
No
Devise: 
CAD

MindBio is a leading biotech/biopharma company focused on creating novel and emerging treatments for mental health conditions and is conducting world first take-home Microdosing (MB22001) human clinical trials.  MB22001 is MindBio’s lead candidate drug, a proprietary titratable form of Lysergic Acid Diethylamide (LSD) designed for take-home microdosing.  MindBio is a leader in microdosing of psychedelic medicines and is advancing its drug and technology protocols through clinical trials. MindBio has developed a multi-disciplinary platform for developing treatments and is involved in psychedelic medicine development and digital therapeutics, has completed Phase 1 clinical trials in 80 healthy participants, has a Phase 2a clinical trial just completed microdosing in patients with Major Depressive Disorder and a Phase 2B clinical trial currently underway microdosing in late stage cancer patients experiencing existential distress. The Company has also started dosing in a Phase 2B Depression Trial.   MindBio invests in research that forms the basis for developing novel and clinically proven treatments including digital technologies and interventions to treat debilitating health conditions such as depression, anxiety and other related mental health conditions.

MindBio Therapeutics Corp. (MBIO)

0.01 Up
0.005 (100.00%)

MindBio Therapeutics Corp. (MBIO)

*Financial charts powered by Quotemedia.com. All right reserved. View the Terms of Use. Data delayed 15 minutes unless indicated.

Citation

Quantité demandé
1,671,000 
Cours acheteur
0.005 
Cours vendeur
0.01 
Quantité offerte
355,000 
Volume
405,556 
Dernier prix
0.01 
Écart minimum
Up 
variation nette
0.005 
Clôture précédente
0.005 
Ouverture
0.01 
Day High
0.01 
Day Low
0.01 
Haut 52 semaines
0.07 
Bas 52 semaines
0.005 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quantité demandé
Cours acheteur
0.00 
Cours vendeur
0.00 
Quantité offerte
Volume
Dernier prix
0.02 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.02 
Ouverture
0.00 
Day High
0.00 
Day Low
0.00 
Haut 52 semaines
 
Bas 52 semaines
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Citation

Quantité demandé
1,671,000 
Cours acheteur
0.005 
Cours vendeur
0.01 
Quantité offerte
355,000 
Volume
405,556 
Dernier prix
0.01 
Écart minimum
Up 
variation nette
0.005 
Clôture précédente
0.005 
Ouverture
0.01 
Day High
0.01 
Day Low
0.01 
Haut 52 semaines
0.07 
Bas 52 semaines
0.005 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Quantité demandé
Cours acheteur
0.00 
Cours vendeur
0.00 
Quantité offerte
Volume
Dernier prix
0.02 
Écart minimum
Up 
variation nette
 
Clôture précédente
0.02 
Ouverture
0.00 
Day High
0.00 
Day Low
0.00 
Haut 52 semaines
 
Bas 52 semaines
 
 
 
 
 

*Note: Bid Size and Ask Size fields are displayed as actual quantities

Profondeur de marche par ordre

  • MBIO / Dernière mise à jour: 15:36:36 ET
  • Refresh
  • Info
Courtier Bid Quantité demandé Cours acheteur Cours vendeur Quantité offerte Demandez Broker
Desjardins Securities Inc. 34,000 0.005 0.01 5,000 National Bank Financial Inc.
RBC Capital Markets 200,000 0.005 0.01 350,000 Anonymous
TD Securities Inc. 150,000 0.005 0.015 60,000 National Bank Financial Inc.
TD Securities Inc. 150,000 0.005 0.015 10,000 CIBC World Markets Inc.
National Bank Financial Inc. 118,000 0.005 0.015 150,000 BMO Nesbitt Burns Inc.
TD Securities Inc. 100,000 0.005 0.015 7,000 National Bank Financial Inc.
TD Securities Inc. 50,000 0.005 0.02 20,000 National Bank Financial Inc.
CIBC World Markets Inc. 33,000 0.005 0.02 25,000 BMO Nesbitt Burns Inc.
BMO Nesbitt Burns Inc. 280,000 0.005 0.02 20,000 National Bank Financial Inc.
TD Securities Inc. 60,000 0.005 0.02 100,000 TD Securities Inc.
Courtier Bid Quantité demandé Cours acheteur Cours vendeur Quantité offerte Demandez Broker
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0
0 0.00 0.00 0

Profondeur d'affichage de prix

  • MBIO / Dernière mise à jour: 15:36:36 ET
  • Refresh
  • Info
Acheteur Quantité demandé Cours acheteur Cours vendeur Quantité offerte Vendeur
21 1,671,000 0.005 0.01 355,000 2
0 0 0.00 0.015 227,000 4
0 0 0.00 0.02 244,000 8
0 0 0.00 0.025 79,000 4
0 0 0.00 0.03 163,000 9
Acheteur Quantité demandé Cours acheteur Cours vendeur Quantité offerte Vendeur
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0
0 0 0.00 0.00 0 0

Métiers récents

  • MBIO / Dernière mise à jour: 12:52:03 ET
  • Refresh
  • Info
Date/Heure Prix Modifier Volume Acheteur Vendeur Venue
Apr 7, 16:52 0.01 0.005 3,000 TD Securities Inc. National Bank Financial Inc. CSE
Apr 7, 13:57 0.01 0.005 2,000 TD Securities Inc. National Bank Financial Inc. CSE
Apr 7, 13:56 0.01 0.005 230,000 TD Securities Inc. Anonymous CSE
Apr 7, 13:56 0.01 0.005 20,000 TD Securities Inc. CIBC World Markets Inc. CSE
Apr 7, 13:56 0.01 0.005 20,000 TD Securities Inc. National Bank Financial Inc. CSE

Information d'entreprise

Addresse
1055 West Georgia Street,1500 Royal Centre P.O Box 11117
Vancouver, BC V6E 4N7
Canada
Téléphone
+61 4331140886
Courriel
Justin@MindBiotherapeutics.com
URL
https://www.mindbiotherapeutics.com
Date d’inscription à la cote
Vendredi, mai 5, 2023
Agent de transfert
Odyssey Trust Company

SEDAR Information

Type de dossier Tout News Releases Management's Discussion & Analysis Financial Statements Material Change Report
Délai @count semaine@count mois3 month6 month@count annéeTout le temps

Information d'entreprise

Addresse
1055 West Georgia Street,1500 Royal Centre P.O Box 11117
Vancouver, BC V6E 4N7
Canada
Téléphone
+61 4331140886
Courriel
Justin@MindBiotherapeutics.com
URL
https://www.mindbiotherapeutics.com
Date d’inscription à la cote
Vendredi, mai 5, 2023
Agent de transfert
Odyssey Trust Company

Capitalisation

Capitalisation: 
177957291
Réservé à l'émission: 
12127309

Company Officers

Justin Hanka, Chief Executive Officer and Director
Gavin Upiter, Non-Executive Director and Chairman
Dr Zena Burgess, Non Executive Director

Bulletins

04/05/2023

2023-0505 - Nouvelles Inscriptions - MindBio Therapeutics Corp. (MBIO)

le 4 mai/May 2023

The common shares of MindBio Therapeutics Corp. have been approved for listing on the CSE.

Listing and disclosure documents will be available at www.thecse.com on the trading date.